Side-by-side comparison of AI visibility scores, market position, and capabilities
Wisp is a telehealth platform for women's sexual and reproductive health providing online consultations and medication delivery for birth control, UTIs, and sexual wellness.
Wisp is a women's health telehealth company founded in 2018 that provides convenient online care for sexual and reproductive health conditions including birth control, UTIs, STI treatment, yeast infections, bacterial vaginosis, and sexual wellness. The platform allows patients to consult with licensed providers online and receive prescription medications delivered by mail within 24 to 48 hours without requiring an in-person visit. Wisp operates in all 50 US states and has served over a million patients through its digital-first model. The company raised $25M and targets working women who want convenient access to reproductive health care without taking time off for in-person appointments. Wisp differentiates from general telehealth platforms by specializing exclusively in women's sexual and reproductive health, with clinical protocols and provider training optimized for the conditions most frequently experienced by women. The company offers both one-time treatment consultations and subscription plans for ongoing contraception management. Wisp has built a strong consumer brand through social media and content marketing focused on normalizing conversations about women's sexual health.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.